Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank76
3Y CAGR+92.1%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+92.1%/yr
Quarterly compound
Percentile
P76
Within normal range
vs 3Y Ago
7.1x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 11.01% |
| Q3 2025 | -57.16% |
| Q2 2025 | 25.48% |
| Q1 2025 | -13.68% |
| Q4 2024 | 8.43% |
| Q3 2024 | -3.22% |
| Q2 2024 | 14.53% |
| Q1 2024 | -0.66% |
| Q4 2023 | -11.39% |
| Q3 2023 | -49.52% |
| Q2 2023 | 39.23% |
| Q1 2023 | -32.71% |
| Q4 2022 | 1.55% |
| Q3 2022 | 32.44% |
| Q2 2022 | -21.10% |
| Q1 2022 | 44.60% |
| Q4 2021 | -48.50% |
| Q3 2021 | -8.49% |
| Q2 2021 | 21.23% |
| Q1 2021 | -50.92% |
| Q4 2020 | -16.77% |
| Q3 2020 | 7.41% |
| Q2 2020 | 14.69% |
| Q1 2020 | -36.03% |
| Q4 2019 | -12.01% |
| Q3 2019 | -42.20% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |